Clinical Trials Browser

Interventional × daratumumab × Thoracic × Clear all

NCT06015724 2026-05-15

DARANIVOVAX

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05807048 2026-03-10

Daratumumab in STK11 Mutated NSCLC

Phase 2 Completed

Non-small Cell Lung Cancer With STK11/LKB1 Mutation

NCT03098550 2021-07-23

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Phase 1/2 Completed

105 enrolled 21 charts

BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT03023423 2019-11-20

DARZALEX

Phase 1/2 Completed

100 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung